LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5411 | 5667 | 0.9548 | 0.9401 |
MCF7 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6120 | 5667 | 1.0798 | 1.1057 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5969 | 5667 | 1.0531 | 1.0704 |
MCF7 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 727 | 5667 | 0.1283 | -0.1547 |
MCF7 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4320 | 5667 | 0.7622 | 0.6851 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5239 | 5667 | 0.9244 | 0.8999 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6297 | 5667 | 1.1111 | 1.1471 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4267 | 5667 | 0.7529 | 0.6727 |
MCF7 | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5533 | 5667 | 0.9762 | 0.9685 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3839 | 5667 | 0.6774 | 0.5727 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1513 | 5667 | 0.2670 | 0.0290 |
MCF7 | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5070 | 5667 | 0.8946 | 0.8604 |
MCF7 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6139 | 5667 | 1.0832 | 1.1102 |
MCF7 | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5185 | 5667 | 0.9148 | 0.8871 |
MCF7 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6042 | 5667 | 1.0661 | 1.0875 |
MCF7 | R406 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4780 | 5667 | 0.8434 | 0.7926 |
MCF7 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 2668 | 5667 | 0.4708 | 0.2991 |
MCF7 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5921 | 5667 | 1.0448 | 1.0593 |
MCF7 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3677 | 5667 | 0.6487 | 0.5347 |
MCF7 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3461 | 5667 | 0.6106 | 0.4842 |
MCF7 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6304 | 5667 | 1.1123 | 1.1488 |
MCF7 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5101 | 5667 | 0.9001 | 0.8677 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3648 | 5667 | 0.6437 | 0.5280 |
MCF7 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1402 | 5667 | 0.2475 | 0.0032 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4087 | 5667 | 0.7211 | 0.6305 |